physician photo

Adetunji T. Toriola, MD, PhD

Assistant Professor of Surgery




Learn more about Dr. Toriola's research

Medical School

MD, Obafemi Awolowo University, Ile-Ife, Nigeria, 1998
DA (Diploma in Anesthesia), West African College of Surgeons, 2004

Graduate School

MPH (Master of Science in Public Health), University of Kuopio, Kuopio, Finland, 2007
PhD (Epidemiology), University of Tampere, Tampere, Finland, 2011

Post Doctoral Education

Postdoctoral Fellowship, German Cancer Research Center (DKFZ), Heidelberg, Germany, 2011-2012

Honors and Awards

2004: Travel Fellowship Award, Obstetrics Anesthetics Association of UK
2007: Scholarship, European Union Cancer Control using Population based Registries and Biobank (EU-CCPRB) and University of Tampere, Finland
2008: Global Health Travel Award, Bill and Melinda Gates Foundation and Keystone
2010: Scholarship, European Association for Cancer Research
2010: Poster Prize Award, European Society for Biomedical Research on Alcoholism Symposium, Heidelberg, Germany
2010: Travel Fellowship Award, European Association for Cancer Research.
2011: Post-doctoral Fellowship Award, German Cancer Research Center (DKFZ), Heidelberg, Germany
2011: Travel Award, GlaxoSmithKline (GSK)
2013: Integrative Molecular Epidemiology Workshop, American Association for Cancer Research (AACR), Selected Participant
2013: Faculty Diversity Scholar, Washington University School of Medicine

Research Interests

Dr. Toriola’s research interest focuses on the use of biomarkers to investigate the associations of energetics, hormones and inflammation with cancer risk and survival. He is especially interested in the interplay between inflammation and insulin resistance in cancer risk and mortality and the translational importance of such relationship. He has taken leading roles in studies conducted within large cohorts such as the Women’s’ Health Initiative Observational Study, Finnish Maternity Cohort, Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial and Kuopio Ischemic Heart Disease Risk Factor Study.

Contact Information

660 S. Euclid Avenue
Campus Box 8100
St. Louis, MO 63110
(314) 268-2668
a.toriola@wustl.edu

Selected Publications

Toriola AT, Fields R. Inflammatory, insulin resistance metabolic markers and pancreatic cancer: Quo vadis. Future Oncology 2014 (In press).

Toriola AT, Stolzenberg-Solomon R, Dalidowitz L, Linehan D, Colditz G. Diabetes and pancreatic cancer survival: a prospective cohort-based study. Br J Cancer 2014 (In press).

Toriola AT, Nguyen N, Scheitler-Ring K, Colditz G. Circulating 25-hydroxyvitamin D (25-OHD) levels and prognosis among cancer patients: a systematic review. Cancer Epidemiol Biomark Prev. 2014 (In press).

Ulrich CM, *Rankin C, *Toriola AT, Makar KW, Altug-Teber Ö, Benedetti JK, Holmes RS, Smalley SR, Blanke DS, Lenz H-J. Polymorphisms in folate-metabolizing enzymes and response to 5-fluorouracil among stage II or III rectal cancer patients (INT-0144; SWOG 9304). Cancer 2012 (In press). *Equal contribution.

Toriola AT, Laukannen JA, Kurl S, Nyyssonen K, Ronkainen K, Kauhanen J. Pre-diagnostic circulating markers of inflammation and risk of prostate cancer. International Journal of Cancer 2013:133 (12); 2961-7.

Kraus S, Hummler S, Toriola AT, Poole EM, Scherer D, Kotzmann J, Makar KW, Kazanov D, Galazan L, Naumov I, Coghill AE, Duggan D, Gigic B, Arber N, Ulrich CM. Impact of genetic polymorphisms on adenoma recurrence and toxicity in a COX-2 inhibitor (celecoxib) trial: results from a pilot study. Pharmacogenetics and genomics 2013;23(8):428-37.

Toriola AT, Colditz GA. Trends in breast cancer incidence and mortality in the United States: implications for prevention. Breast Cancer Res Treat 2013;138(8):665-73.

Ulrich CM, Toriola AT, Siegel EM, Brenner H, Chang-Claude J, Abbenhardt C, Kotzmann J, Song X, Owen RW, Hoffmeister H, Becher B, Shibata S, Vickers K, Rush SK, Makar K, Würtele G, Haubner R, Sellers TA, Grady on behalf of the ColoCare Consortium. Plasma 25(OH)D3, folate, and vitamin B12 biomarkers among international colorectal cancer patients: a pilot study. J Nutr Sci (In press).

Toriola AT, Cheng T-YD, Neuhouser ML, Wener MH, Zheng Y, Brown E, Miller JW, Song X, Beresford SAA, Gunter MJ, Caudill MA, Ulrich CM. Biomarkers of inflammation are associated with colorectal cancer risk in women but are not suitable as early detection markers. Int J Cancer 2013:132(11):2648-59

Ulrich CM, Toriola AT, Koepl LM, Sandifer T, Poole EM, Duggan C, McTiernan A, Issa JP. Metabolic, hormonal and immunological associations with global DNA methylation among postmenopausal women. Epigenetics 2012;7(9):1020-1028

Toriola AT, Ulrich CM. Is there a potential use for C-reactive protein as a diagnostic and prognostic marker for colorectal cancer? Future Oncology 2011; 7(10): 1125-8.

Toriola AT, Surcel H-M, Lundin E, Schock H, Grankvist K, Pukkala E, Chen T, Toniolo P, Lehtinen M, Zeleniuch-Jacquotte A, Lukanova A. Insulin-like growth factor-I and C-reactive protein during pregnancy and maternal risk of non-epithelial ovarian cancer: a nested case-control study. Cancer Causes Control 2011; 22:1607-1611.

Toriola AT, Grankvist K, Agborsangaya C, Lukanova A, Lehtinen M, Surcel HM. Changes in C-reactive protein concentrations and the risk of ovarian cancer: a longitudinal study. Ann Oncol 2011; 22(8): 1916-1921.

Toriola AT, Lundin E, Lehtinen M, Grankvist K, Pukkala E, Chen T, Zeleniuch-Jacquotte A, Toniolo P, Lehtinen M, Surcel HM, Lukanova A. Circulating insulin-like growth factor-I in pregnancy and maternal risk of breast cancer. Cancer Epidemiol Biomark Prev 2011;20(8):1798-1801. PMID: 21680537 PMCID: PMC3153607

Toriola AT, Surcel H-M, Agborsangaya C, Grankvist K, Luostarinen T, Lukanova A, Pukkala E, Lehtinen M. Independent and joint effects of serum 25-hydroxyvitamin D and calcium on ovarian cancer risk: a prospective nested case-control study. Eur J Cancer 2010;46;2799-2805.

Pub Med page for Adetunji Toriola, MD, PhD

Editorial Positions

Reviewer for:

Annals of Oncology
British Journal of Cancer
Canadian Medical Association Journal
Cancer Causes and Control
Cancer Epidemiology Biomarkers and Prevention
Carcinogenesis
Diabetic Medicine
International Journal of Cancer
Tumor Biology